← All companiesAAkari Therapeutics Plc
AKTX - CIK 0001541157
Akari Therapeutics Plc net income by year
Akari Therapeutics Plc (AKTX) reported net income of -$17.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
AKTX annual net income
AKTX net income 2011-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$17.30M | +12.6% |
| FY 2024 | -$19.80M | -97.8% |
| FY 2023 | -$10.01M | +23.5% |
| FY 2022 | -$13.09M | +24.9% |
| FY 2021 | -$17.42M | -2.0% |
| FY 2020 | -$17.08M | -1.4% |
| FY 2019 | -$16.85M | +17.8% |
| FY 2018 | -$20.50M | +42.1% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Akari Therapeutics Plc make?
Akari Therapeutics Plc (AKTX) reported net income of -$17.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Akari Therapeutics Plc's net income changed over time?
Between fiscal 2011 and fiscal 2025, Akari Therapeutics Plc's net income declined from -$2.12M to -$17.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.